Company intelligence / Profile preview

Humanscape

Ownership: Private
Development stage: Commercial

Overview

Humanscape operates commercialized digital platforms focused on rare disease patient communities, clinical trial data management, and pregnancy/parenting support. Its Rarenote service aggregates real-world patient data to inform research and new drug development in the rare disease space. The company has demonstrated strong user adoption with over 930,000 users on its Momitalk app. No direct therapeutic or clinical results as it does not develop drugs.

Therapeutic areas: OtherRare DiseasesWomen's Health
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Humanscape.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humanscape.

Explore the full profile